Effects of cancer immunotherapy with indomethacin and interleukin-2 on murine hemopoietic stem cells.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Effects of cancer immunotherapy with indomethacin and interleukin-2 on murine hemopoietic stem cells.

Cancer research - 1 Dec 1992

Saarloos M N, Khoo N K, Lala P K

Abstract excerpt

We examined: (a) whether in vitro-generated lymphocyte-activated killer (LAK) cells from normal mice and splenic killer cells from tumor-bearing mice subjected to interleukin-2 (IL-2) therapy alone or in combination with chronic indomethacin therapy have any detrimental effects on the spleen colo...

Topics

Animals
Cell Count
Female
Hematopoietic Stem Cells
Immunotherapy
Indomethacin
Interleukin-2
Killer Cells, Lymphokine-Activated
Lung Neoplasms
Mammary Neoplasms, Animal
Mice
Mice, Inbred C3H
Neoplasm Transplantation
Phenotype
Spleen
Tumor Stem Cell Assay

Source

Open in PubMed

Identifiers

PMID: 1423293

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-1423293-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics